Intelligent Bio Solutions Scales Reach Throughout Asia-Pacific Region with Addition of Sales Team in Australia, New Distribution Hub and Office Facility
May 02, 2023 07:30 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...
UK Food Processing Equipment Manufacturer Latest to Adopt Intelligent Bio Solutions’ Portable Fingerprint Drug Testing Solution
April 26, 2023 08:00 ET
|
Intelligent Bio Solutions, Inc.
“Having experienced urine drug testing myself, I know it’s not a pleasant experience for anyone. So, when it came to selecting a drug screening approach for Dodman, it was clear that fingerprint...
Intelligent Bio Solutions Secures UK Patent for Intelligent Fingerprinting DSR-Plus Cartridge Reader
April 18, 2023 07:30 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...
A & F Sprinklers Selects Intelligent Bio Solutions’ Latest DSR-Plus Screening Unit to Support its Random Drug Screening Program
March 27, 2023 07:30 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, March 27, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), today announced that A & F Sprinklers, one of the UK’s leading fire...
Intelligent Bio Solutions Inc. Selects HASTA Laboratory as Drug Testing Specialist in Australia
March 13, 2023 08:30 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, March 13, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("Intelligent Bio Solutions" or the "Company") (Nasdaq: INBS), a life sciences company developing and delivering...
Intelligent Bio Solutions Inc. Announces Closing of $2.55 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares and Warrants
March 10, 2023 16:01 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, March 10, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company developing and delivering intelligent, non-invasive, real-time...
Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering
March 08, 2023 08:30 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, March 08, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company developing and delivering intelligent, non-invasive, real-time...
Intelligent Bio Solutions Inc. Announces Proposed Public Offering
March 07, 2023 16:07 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company developing and delivering intelligent, non-invasive, real-time...
Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Listing Requirement
March 01, 2023 08:30 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("Intelligent Bio Solutions" or the "Company") (Nasdaq: INBS), a life sciences company developing and delivering...
Intelligent Bio Solutions Inc. files FDA 513(g) regulatory submission for Intelligent Fingerprinting Drug Screening Cartridge
February 16, 2023 08:30 ET
|
Intelligent Bio Solutions, Inc.
- 513(g) submission will allow Intelligent Bio Solutions Inc. to determine the most suitable FDA regulatory pathway for its Intelligent Fingerprinting Drug Screening Cartridge, as the next step in its...